Results 131 to 140 of about 10,873 (203)

Mineralocorticoid Receptor Antagonists for Liver Fibrosis: Potential Mechanisms and Research Progress. [PDF]

J Clin Transl Hepatol
Zheng H, Feng Y.
europepmc   +1 more source

Serum Potassium and Mineralocorticoid Receptor Antagonists As Modifiers of Atrial Arrhythmia Recurrence After Catheter Ablation for Atrial Fibrillation: A Narrative Review With Systematic Search and Mechanistic Synthesis. [PDF]

Cureus
Tomita S, Kishi T.
europepmc   +1 more source

Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: Clinical Evidence, Pharmacology, and Drug-Drug Interactions for Personalized Management of Hyperkalemia. [PDF]

Int J Mol Sci
Hirai T, Katayama K.
europepmc   +1 more source

The novel mineralocorticoid receptor modulator balcinrenone protects against diet-induced cardiac microvascular dysfunction and plasma potassium elevation in mouse models. [PDF]

PLoS One
Wolf MJ, El Moghrabi S, Palacios-Ramirez R, Bamberg K, Bradley LA, Epstein FH, Hartleib-Geschwindner J, Jaisser F.   +7 more
europepmc   +1 more source

Long-term follow-up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half-dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4. [PDF]

Acta Ophthalmol
Feenstra HMA, El Mansori I, van Rijssen TJ, Tsonaka R, Diederen RMH, Hoyng CB, Schlingemann RO, Boon CJF, van Dijk EHC.   +8 more
europepmc   +1 more source

Eplerenone lowers maternal blood pressure in a model of leptin-induced preeclampsia, but decreases fetal growth when administered mid-, but not late-, gestation. [PDF]

Am J Physiol Heart Circ Physiol
Mellott E, Moronge D, Cooper G, Backer K, Connor G, Elgazzaz M, Ogbi S, Faulkner JL.   +7 more
europepmc   +1 more source

Chronic Musculoskeletal Pain as an Initial Presentation of Gitelman Syndrome in Adulthood: A Case Report. [PDF]

Cureus
Nair S, Michel M L, Kumar K, Fathima NM, Jacob HR.   +4 more
europepmc   +1 more source

Dissecting the role of mineralocorticoid receptors in binge-like alcohol drinking in mice: Finerenone as a potential pharmacotherapy. [PDF]

Psychopharmacology (Berl)
Wilkinson CS, Bruns N, Pince CL, McGinn MA, Farokhnia M, Leggio L, Vendruscolo LF.   +6 more
europepmc   +1 more source

Nonsteroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Mechanistic Basis, Clinical Evidence, and Therapeutic Integration. [PDF]

Drugs Drug Candidates
Al-Horani RA, Goyal N.
europepmc   +1 more source

Review of Hyperkalemia Profile for Mineralocorticoid Receptor Antagonist in Patients with Chronic Kidney Disease and Type 2 Diabetes.

Cardiorenal Med
Kendrick JB, Dixon AM.
europepmc   +1 more source